Monte Rosa Therapeutics, Inc
Monte Rosa Therapeutics seeks a High-Throughput Cellular Assay expert to develop and optimize assays for screening and compound profiling in protein degradation research. The role involves cultivating cell lines, utilizing automation for high-throughput experiments, maintaining electronic lab notebooks, and collaborating across functions to drive program decisions. Candidates will work within an innovative environment dedicated to eliminating disease-causing proteins through targeted approaches.
Monte Rosa Therapeutics is a biotechnology company pioneering molecular glue degrader (MGD) therapies that promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, traditionally undruggable proteins. Their drug discovery platform integrates expertise in MGD chemistry, artificial intelligence, structural biology, and proteomics to rapidly advance programs targeting undruggable or inadequately drugged targets with unprecedented specificity. Focused on cancer and beyond, the company operates out of Boston, MA and Basel, Switzerland.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc didn’t post a salary, so this is our estimate from similar listings.
Molecular Pharmacology Scientist
Miami-Dade County
Associate Director, Head of Cellular Lead Profiling
Takeda Pharmaceutical Company Limited
Molecular Pharmacology Scientist
New York State
Associate Director | High-Throughput Biology
Digital Biology
Principal Scientist – Lead Discovery and Targeted Protein Degradation Biochemistry
Amgen
Senior Research Scientist Platform Biology
Arvinas